Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

Healthcare Biotechnology

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > Y/E Financials

<< Previous

Bullboard Posts

Comment by Chefboy69on Dec 20, 2024 6:19pm

25 Views

Post# 36373081

RE:Y/E Financials

It's a pharmaceutical company bro they're not going to be making lots of money right now the money is in the Partnerships that they have and very soon Nick is going to be doing a partnership with a major pharmaceutical company and that will make this stock very valuable. Market is Forward Thinking why are you thinking about financials right now

<< Previous

Bullboard Posts

Eminent acquires promising Nevada gold project